Norway· NO-ID_581409DE-2569-4AA4-9B25-8AD9D88FE8E2
Blenrep
A belantamab mafodotin product containing belantamab mafodotin, registered in Norway by GlaxoSmithKline Trading Services Limited. The same ATC class is registered in 12 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Belantamab mafodotin is registered in 12 of 19 countries.
Countries holding a registration under ATC L01FX15 (belantamab mafodotin), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Belantamab mafodotin · ATC L01FX15
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Belantamab Mafodotin
- Manufacturer
- GlaxoSmithKline Trading Services Limited
- Country
- Norway (NO)
- ATC code
- L01FX15
- ATC class
- Belantamab mafodotin
- Defined daily dose
- 8.3 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_581409DE-2569-4AA4-9B25-8AD9D88FE8E2
- no_varenummer4206911NOK 544609.1
- gtin5054290011746
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
58 interactions on record for belantamab mafodotin.
Graded by severity as the source publishes them — 28 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Belantamab mafodotin · interactions on record
58 records
- 28 severe
- 30 moderate
Most severe, free to view
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- Talimogen laherparepvecL01XX51severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Belantamab mafodotin in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenBlenrep 100 mg Pulver till koncentrat till infusionsvätska, lösningGlaxoSmithKline (Ireland) Limited
- SpainBLENREP 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONGlaxosmithkline Trading Services Limited
- FinlandBlenrepGlaxoSmithKline (Ireland) Limited
- United KingdomBlenrep 100mg powder for concentrate for solution for infusion vialsImported (Ireland)
- BelgiumBlenrep 100 mgGlaxoSmithKline
- PolandBlenrepGlaxoSmithKline Trading Services Limited
- SwitzerlandBlenrep 100 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungGlaxoSmithKline AG
- CzechiaBLENREPGlaxoSmithKline Trading Services Limited, Dublin
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Blenrep
- Liechtenstein · Blenrep
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cded3785-b35c-45ef-a441-bddd3100384f GET /v1/drugs/cded3785-b35c-45ef-a441-bddd3100384f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver til konsentrat til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Belantamabmafodotin",
"merkevare_id": "ID_581409DE-2569-4AA4-9B25-8AD9D88FE8E2",
"name_form_strength": "Blenrep pulv til kons til inf væske, oppl 100 mg",
"prescription_group": "C"
}See everything about belantamab mafodotin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.